Healthcare · Active clinical trials
Kazakhstan is not yet involved in active clinical trials — in 2026, 35 units were recorded. This is due to insufficient integration into international pharmaceutical research and a weak laboratory base. Instead, the republic focuses on purchasing ready-made drugs and developing its own generic production, especially in the Karaganda and Almaty regions.
Data for 2026 · unit: units
Position
#44 / 197
Kazakhstan world ranking
Country position on the scale from last to first place for this indicator.
KZ
#44
#197#1
Trend
Change over time
Change in indicator over the available period.
10
1990
2
2000
10
2010
30
2020
20
2025
35
2026
Values — units
Comparison
Top countries by Active clinical trials
Where Kazakhstan stands in the world ranking.
1
USUSA
12 K
1
CNChina
12 K
3
GBUnited Kingdom
3.5 K
3
JPJapan
3.5 K
5
INIndia
2.5 K
6
FRFrance
1.5 K
6
CACanada
1.5 K
8
DEGermany
1.2 K
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Active clinical trials in Kazakhstan — how much?
Based on 2026 data — 35 units. This is rank #44 out of 197 countries.
What is Kazakhstan's rank by Active clinical trials?
Kazakhstan ranks #44 out of 197 countries in the world ranking by «Active clinical trials».
How has Active clinical trials changed in Kazakhstan?
Over the available period the indicator changed from 10 to 35 units.